kabutan

SANTEN PHARMA, 6% Decrease in Net Income for The Current Fiscal Year, Dividend Raised by 2 yen

Tue May 13, 2025 3:30 pm JST Earnings

4536 SANTEN PHARMACEUTICAL CO.,LTD. 【IFRS】

Earnings Report

SANTEN PHARMACEUTICAL CO.,LTD. <4536> [TSE Prime] announced its financial results (based on IFRS) after the market closed on May 13th (15:30). The consolidated net income for the fiscal year ending March 2025 expanded 36.1% from the previous period to 36.2 billion yen. However, for the fiscal year ending March 2026, the consolidated net income is expected to decrease by 6.2% from the previous period to 34 billion yen.

At the same time, the company has decided to increase the dividend this fiscal year to 38 yen, an increase of 2 yen from the previous fiscal year.

In the most recent three-month period, from January to March (4Q), the consolidated net income surged 303 times that of the same period last year, reaching 8.79 billion yen. The operating profit margin drastically improved from 3.0% in the same period last year to 15.1%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 279,037 -3,090 -5,799 -14,948 -38.6 32 May 11, 2023 IFRS
Mar, 2024 301,965 38,541 29,874 26,642 72.6 33 May 9, 2024 IFRS
Mar, 2025 300,004 46,880 47,481 36,256 104.0 36 May 13, 2025 IFRS
YoY -0.6% +21.6% +58.9% +36.1% +43.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 302,000 44,500 45,000 32,500 95.2 36 Feb 6, 2025 IFRS
Mar, 2025 Results 300,004 46,880 47,481 36,256 104.0 36 May 13, 2025 IFRS
Revision Rate -0.7% +5.3% +5.5% +11.6% +9.2%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 146,404 23,873 23,839 18,772 52.9 17 Nov 7, 2024 IFRS
Apr - Sep, 2025 Guidance ー ー ー ー － 19 May 13, 2025 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 301,965 38,541 29,874 26,642 72.6 33 May 9, 2024 IFRS
Mar, 2025 300,004 46,880 47,481 36,256 104.0 36 May 13, 2025 IFRS
Mar, 2026 Guidance 294,000 44,000 33,500 34,000 105.7 38 May 13, 2025 IFRS
YoY -2.0% -6.1% -29.4% -6.2% +1.7%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 79,132 2,384 -3,685 29 0.1 3.0 May 9, 2024 IFRS
Apr - Jun, 2024 74,771 13,155 13,450 10,633 29.6 17.6 Aug 6, 2024 IFRS
Jul - Sep, 2024 71,633 10,718 10,389 8,139 22.9 15.0 Nov 7, 2024 IFRS
Oct - Dec, 2024 76,369 11,322 11,470 8,693 24.8 14.8 Feb 6, 2025 IFRS
Jan - Mar, 2025 77,231 11,685 12,172 8,791 25.2 15.1 May 13, 2025 IFRS
YoY -2.4% +390.1% － +30,213.8% +31,412.5%

Related Articles